Herve Tilly
AuthID: R-00G-YRG
1
TÃTULO: Six-Year Results from the Phase 3 Randomized Study Relevance Show Similar Outcomes for Previously Untreated Follicular Lymphoma Patients Receiving Lenalidomide Plus Rituximab (R (2)) Versus Rituximab-Chemotherapy Followed By Rituximab Maintenance
AUTORES: Morschhauser, Franck; Nastoupil, Loretta; Feugier, Pierre; De Colella, Jean Marc Schiano; Tilly, Herve; Palomba, M. Lia; Bachy, Emmanuel; Fruchart, Christophe; Libby, Edward; Casasnovas, Rene Olivier; Flinn, Ian W.; Haioun, Corinne; Maisonneuve, Herve; Ysebaert, Loic; Bartlett, Nancy L.; Bouabdallah, Kamal; Brice, Pauline; Ribrag, Vincent; Le Gouill, Steven; Daguindau, Nicolas; ...Mais
PUBLICAÇÃO: 2021, FONTE: BLOOD, VOLUME: 138
AUTORES: Morschhauser, Franck; Nastoupil, Loretta; Feugier, Pierre; De Colella, Jean Marc Schiano; Tilly, Herve; Palomba, M. Lia; Bachy, Emmanuel; Fruchart, Christophe; Libby, Edward; Casasnovas, Rene Olivier; Flinn, Ian W.; Haioun, Corinne; Maisonneuve, Herve; Ysebaert, Loic; Bartlett, Nancy L.; Bouabdallah, Kamal; Brice, Pauline; Ribrag, Vincent; Le Gouill, Steven; Daguindau, Nicolas; ...Mais
PUBLICAÇÃO: 2021, FONTE: BLOOD, VOLUME: 138
INDEXADO EM: 
WOS
WOS2
TÃTULO: Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study
AUTORES: Herve Tilly; Franck Morschhauser; Olivier Casasnovas; Thierry Jo Molina; Pierre Feugier; Steven Le Gouill; Corinne Haioun; Olivier Tournilhac; Reda Bouabdallah; Jean Gabarre; Thierry Lamy; Jose Cabecadas; Stephanie Becker; Fabrice Jardin; Nicolas Mounier; Gilles Salles;
PUBLICAÇÃO: 2018, FONTE: LANCET HAEMATOLOGY, VOLUME: 5, NÚMERO: 9
AUTORES: Herve Tilly; Franck Morschhauser; Olivier Casasnovas; Thierry Jo Molina; Pierre Feugier; Steven Le Gouill; Corinne Haioun; Olivier Tournilhac; Reda Bouabdallah; Jean Gabarre; Thierry Lamy; Jose Cabecadas; Stephanie Becker; Fabrice Jardin; Nicolas Mounier; Gilles Salles;
PUBLICAÇÃO: 2018, FONTE: LANCET HAEMATOLOGY, VOLUME: 5, NÚMERO: 9
INDEXADO EM: 
Scopus WOS
Scopus WOS3
TÃTULO: Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial
AUTORES: Clementine Sarkozy; Marek Trneny; Luc Xerri; Nick Wickham; Pierre Feugier; Sirpa Leppa; Pauline Brice; Pierre Soubeyran; Maria Gomes Da Silva; Christiane Mounier; Fritz Offner; Jehan Dupuis; Dolores Caballero; Danielle Canioni; Marlton Paula; Richard Delarue; Pierre Zachee; John Seymour; Gilles Salles; Herve Tilly;
PUBLICAÇÃO: 2016, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 34, NÚMERO: 22
AUTORES: Clementine Sarkozy; Marek Trneny; Luc Xerri; Nick Wickham; Pierre Feugier; Sirpa Leppa; Pauline Brice; Pierre Soubeyran; Maria Gomes Da Silva; Christiane Mounier; Fritz Offner; Jehan Dupuis; Dolores Caballero; Danielle Canioni; Marlton Paula; Richard Delarue; Pierre Zachee; John Seymour; Gilles Salles; Herve Tilly;
PUBLICAÇÃO: 2016, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 34, NÚMERO: 22
4
TÃTULO: Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial Full Text
AUTORES: Gilles Salles; John Francis Seymour; Fritz Offner; Armando Lopez Guillermo; David Belada; Luc Xerri; Pierre Feugier; Reda Bouabdallah; John Vincent Catalano; Pauline Brice; Dolores Caballero; Corinne Haioun; Lars Moller Pedersen; Alain Delmer; David Simpson; Sirpa Leppa; Pierre Soubeyran; Anton Hagenbeek; Olivier Casasnovas; Tanin Intragumtornchai; ...Mais
PUBLICAÇÃO: 2011, FONTE: LANCET, VOLUME: 377, NÚMERO: 9759
AUTORES: Gilles Salles; John Francis Seymour; Fritz Offner; Armando Lopez Guillermo; David Belada; Luc Xerri; Pierre Feugier; Reda Bouabdallah; John Vincent Catalano; Pauline Brice; Dolores Caballero; Corinne Haioun; Lars Moller Pedersen; Alain Delmer; David Simpson; Sirpa Leppa; Pierre Soubeyran; Anton Hagenbeek; Olivier Casasnovas; Tanin Intragumtornchai; ...Mais
PUBLICAÇÃO: 2011, FONTE: LANCET, VOLUME: 377, NÚMERO: 9759
